MedTrace Logo

Study on Safety and Performance of AdvanCore Bone Void Filler

NCT06736457 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2025-05-31

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and performance of AdvanCore implantable bone graft through a 12-month follow-up period in a prospective, parallel-group design, non-controlled, open label, multi-center and real-world setting study. This study is intended to satisfy post-market clinical follow-up requirements of CE Mark in Europe.

Conditions

  • Bone Fractures
  • Bone Defects
  • Bone Loss
  • Bone Graft

Interventions

PROCEDURE

AdvanCore bone grafting

AdvanCore medical device is implanted making sure that is in direct contact with all surfaces of the defect area.

Sponsors & Collaborators

  • NAMSA

    collaborator OTHER

  • Artur Salgado SA

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-29
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06736457 on ClinicalTrials.gov